Yanyan Jiang Selected Research

Yanyan Jiang Research Topics

Disease

51	Neoplasms (Cancer) 12/2022 - 12/2007
10	Inflammation (Inflammations) 01/2022 - 08/2006
9	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2010
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2022 - 03/2014
5	Cardiotoxicity 09/2022 - 05/2020
5	Neoplasm Metastasis (Metastasis) 08/2022 - 01/2017
5	Lung Neoplasms (Lung Cancer) 01/2021 - 03/2014
5	Body Weight (Weight, Body) 01/2021 - 10/2014
4	Colorectal Neoplasms (Colorectal Cancer) 02/2022 - 03/2020
4	Glioma (Gliomas) 01/2017 - 10/2011
4	Hypoxia (Hypoxemia) 01/2016 - 08/2012
3	Heart Failure 02/2022 - 01/2015
3	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2020
3	Multiple System Atrophy 01/2022 - 01/2021
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2018 - 07/2015
3	Ovarian Neoplasms (Ovarian Cancer) 08/2018 - 11/2014
3	Infections 01/2018 - 04/2009
3	Pre-Eclampsia (Preeclampsia) 05/2012 - 10/2009
3	Brain Injuries (Brain Injury) 10/2008 - 08/2007
2	Triple Negative Breast Neoplasms 08/2022 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 05/2022 - 12/2018
2	Coronary Disease (Coronary Heart Disease) 02/2022 - 02/2021
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 05/2021
2	Acute Promyelocytic Leukemia 09/2021 - 11/2020
2	Myocardial Infarction 02/2021 - 01/2020
2	Brain Neoplasms (Brain Tumor) 01/2017 - 10/2011
2	Carcinoma (Carcinomatosis) 03/2016 - 11/2014
2	Schistosomiasis (Bilharziasis) 01/2016 - 01/2015
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 07/2010 - 04/2009
2	Hypertension (High Blood Pressure) 10/2009 - 08/2009
2	Leukocytosis (Pleocytosis) 10/2008 - 08/2007
2	Central Nervous System Diseases (CNS Diseases) 12/2007 - 08/2007
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2022

Drug/Important Bio-Agent (IBA)

18	Pharmaceutical PreparationsIBA 09/2022 - 01/2009
15	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2022 - 01/2010
11	Biomarkers (Surrogate Marker)IBA 02/2022 - 08/2006
8	PolymersIBA 10/2018 - 10/2011
8	AlbuminsIBA 10/2018 - 11/2014
7	Liposomes (Liposome)IBA 08/2022 - 10/2008
7	Proteins (Proteins, Gene)FDA Link 08/2022 - 12/2007
6	CytokinesIBA 03/2020 - 01/2015
5	DNA (Deoxyribonucleic Acid)IBA 09/2022 - 11/2013
5	Peptides (Polypeptides)IBA 09/2020 - 12/2007
4	MicroRNAs (MicroRNA)IBA 02/2022 - 12/2019
4	Biological ProductsIBA 01/2022 - 07/2015
4	Messenger RNA (mRNA)IBA 01/2018 - 10/2008
4	IntegrinsIBA 01/2017 - 10/2011
4	PAMAM StarburstIBA 05/2015 - 01/2010
4	ChemokinesIBA 07/2010 - 08/2007
3	Gefitinib (Iressa)FDA Link 09/2022 - 03/2014
3	AntibodiesIBA 08/2022 - 01/2015
3	Dacarbazine (DIC)FDA LinkGeneric 03/2021 - 05/2020
3	CurcuminIBA 09/2020 - 03/2016
3	ISIS 5132IBA 10/2018 - 11/2014
3	MicellesIBA 03/2016 - 11/2014
3	AcidsIBA 05/2015 - 02/2010
3	Poly(amidoamine)IBA 05/2015 - 02/2010
3	Transferrin (beta 2 Transferrin)IBA 01/2010 - 12/2007
2	danqi tongmaiIBA 02/2022 - 02/2021
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 11/2017
2	Arsenic Trioxide (Trisenox)FDA Link 09/2021 - 11/2020
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2021 - 01/2016
2	olaparibIBA 01/2021 - 01/2016
2	Hyaluronic Acid (Hyaluronan)IBA 09/2020 - 01/2019
2	Transforming Growth Factor beta (TGF-beta)IBA 03/2020 - 08/2012
2	VaccinesIBA 01/2020 - 01/2015
2	AntigensIBA 01/2020 - 01/2016
2	Estrogens (Estrogen)FDA Link 10/2019 - 08/2009
2	OligonucleotidesIBA 10/2018 - 07/2015
2	poly(2-(dimethylamino)ethyl methacrylate)IBA 10/2018 - 07/2015
2	Radiation-Sensitizing AgentsIBA 01/2018 - 01/2016
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018 - 01/2016
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2018 - 01/2016
2	LeptinIBA 01/2018 - 10/2014
2	polycaprolactoneIBA 12/2017 - 03/2016
2	Neuropilin-1IBA 01/2017 - 10/2014
2	poly(lactide) (polylactic acid)IBA 01/2017 - 11/2013
2	Carmustine (FIVB)FDA Link 01/2017 - 11/2013
2	ChitosanIBA 01/2017 - 11/2013
2	Atrial Natriuretic Factor (ANF)IBA 09/2016 - 01/2015
2	interleukin-21 (interleukin 21)IBA 01/2016 - 01/2015
2	Leptin ReceptorsIBA 01/2016 - 10/2014
2	Histones (Histone)IBA 11/2015 - 12/2013
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 05/2015 - 01/2009
2	Tyrosine Kinase InhibitorsIBA 07/2014 - 03/2014
2	EnzymesIBA 05/2012 - 10/2009
2	Nitric Oxide Synthase (NO Synthase)IBA 05/2012 - 10/2009
2	PEG-PAMAMIBA 10/2011 - 03/2011
2	homocamptothecinIBA 01/2010 - 01/2009
2	hydroxycamptothecinumIBA 01/2010 - 01/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2009 - 12/2007
2	Transferrin Receptors (Transferrin Receptor)IBA 01/2009 - 12/2007
1	Immune Checkpoint InhibitorsIBA 12/2022
1	RNA (Ribonucleic Acid)IBA 12/2022
1	Drug CombinationsIBA 09/2022
1	Monophenol Monooxygenase (Tyrosinase)IBA 09/2022

Therapy/Procedure

25	Therapeutics 12/2022 - 12/2007
4	Drug Therapy (Chemotherapy) 09/2022 - 01/2020
4	Radiotherapy 01/2021 - 03/2014
2	Immunotherapy 08/2022 - 01/2020